Open original FDA record ↗Recall record
- FDA identifier
- Z-0073-2009
- Company in FDA record
- Bard Peripheral Vascular Inc
- FDA classification date
- Oct 10, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Some LifeStent FlexStar Systems may exhibit a gap between the tip of the delivery system and the primary sheath such that the guidewire lumen is visible.
Source facts
- Action
- The customer letters for the tip to sheath gap were sent on 8/29/2008 with return receipt. The letter advises that C.R. Bard has determined that some LifeStent FlexStar Systems may exhibit a gap between the tip of the delivery system and the primary sheath such that the guidewire lumen is visible. Per the letter, the firm's analysis has determined that a gap between the tip of the delivery system and the delivery system sheath may be associated with difficult advancement to the treatment site. Users are instructed to inspect all devices to verify that there is not a gap between the tip and sheath (orange colored guidewire lumen is visible), prior to use and to not use any devices that exhibit a tip to sheath gap condition. If devices that exhibit a tip to sheath gap are identified, customers are advised to call Customer Service at 1-800-321-4254 to return the device and a replacement will be provided at no cost. The letter also advises that the Instructions for Use for the LifeStent FlexStar System will be updated to include the inspection step which is provided in the letter.
- Initiated
- 2008-08-29
- Root cause
- Process control
- Terminated
- 2012-04-06
- Distribution
- Nationwide
- Recall number
- Z-0073-2009
- Recall status
- Terminated
- CDRH record ID
- 73575
- FDA classified
- 2008-10-10
- Recall event number
- 49405